H. Lundbeck A/S (HLBBF)
6.96
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
H. Lundbeck Net Income (Quarterly) : 178.61M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 178.61M |
| March 31, 2026 | 259.64M |
| December 31, 2025 | -4.208M |
| September 30, 2025 | 172.39M |
| June 30, 2025 | 143.25M |
| March 31, 2025 | 158.01M |
| December 31, 2024 | 84.38M |
| September 30, 2024 | 114.41M |
| June 30, 2024 | 111.12M |
| March 31, 2024 | 146.44M |
| December 31, 2023 | 19.32M |
| September 30, 2023 | 98.67M |
| June 30, 2023 | 87.65M |
| March 31, 2023 | 126.85M |
| December 31, 2022 | 42.65M |
| September 30, 2022 | 93.10M |
| June 30, 2022 | 72.24M |
| March 31, 2022 | 62.12M |
| December 31, 2021 | -0.3074M |
| September 30, 2021 | 50.88M |
| June 30, 2021 | 61.28M |
| March 31, 2021 | 100.57M |
| December 31, 2020 | 88.58M |
| September 30, 2020 | 64.80M |
| June 30, 2020 | 77.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.57M |
| December 31, 2019 | 20.89M |
| September 30, 2019 | 111.88M |
| June 30, 2019 | 118.59M |
| March 31, 2019 | 136.62M |
| December 31, 2018 | 100.01M |
| September 30, 2018 | 164.59M |
| June 30, 2018 | 159.72M |
| March 31, 2018 | 197.88M |
| December 31, 2017 | 87.48M |
| September 30, 2017 | 138.34M |
| June 30, 2017 | 90.03M |
| March 31, 2017 | 84.14M |
| December 31, 2016 | 68.52M |
| September 30, 2016 | 47.99M |
| June 30, 2016 | 35.21M |
| March 31, 2016 | 27.49M |
| December 31, 2015 | -65.72M |
| September 30, 2015 | -187.54M |
| June 30, 2015 | -579.02M |
| March 31, 2015 | -12.22M |
| December 31, 2014 | -106.25M |
| September 30, 2014 | 0.8894M |
| June 30, 2014 | 26.46M |
| March 31, 2014 | 60.77M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Novo Nordisk A/S | 3.265B |
| ALK-Abello A/S | 52.74M |
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.014B |
| Total Expenses (Quarterly) | 835.63M |
| EPS Diluted (Quarterly) | 0.18 |
| Enterprise Value | 8.010B |
| Gross Profit Margin (Quarterly) | 79.00% |
| Profit Margin (Quarterly) | 17.61% |
| Earnings Yield | 8.78% |
| Operating Earnings Yield | 15.80% |
| Normalized Earnings Yield | 10.41 |